Butterfly Network BFLY recently announced the availability of its first specialty product, the iQ+ Bladder, in the United States. This launch marks a significant expansion for Butterfly, as it moves ...
A new study reveals that only about 1 in 3 patients with prostate cancer have a successful first CT simulation, while 1 in 6 need to be rescheduled for another day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback